Mode
Text Size
Log in / Sign up
Phase 2 N=88 Randomized Quadruple-blind Treatment

Curcumin and Vascular and Cognitive Function in Patients With Chronic Kidney Disease

Chronic Kidney Diseases · Cognitive Decline

Enrolled (actual)
88
Serious AEs
0.0%
Results posted
Oct 2024
Primary outcome: Primary: Change in Vascular Endothelial Function at 12 Months — -0.1; -0.7 %change

Study Design & Population

Study type
Interventional
Phase
Phase 2
Interventions
Curcumin (Drug); Placebo (Other)
Age
Adult, Older Adult · 45+ yrs
Sex
All
Sponsor
Diana Jalal
Primary completion
Jan 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Vascular Endothelial Function at 12 Months
-0.1; -0.7
SECONDARY
Large Artery Stiffness
0.28; 0.36
SECONDARY
Cognitive Function
2.62; 2.25

Summary

The proposed research is clinical study evaluating the therapeutic benefits of curcumin on vascular function in patients with chronic kidney disease (CKD). The study aims to establish that curcumin will improve endothelial function and reduce large artery stiffness by reducing oxidative stress and in conjunction with lowering markers of inflammation and oxidative stress. In addition, the study will evaluate the potential benefit of curcumin on cognitive function in patients with CKD.

Eligibility Criteria

Inclusion Criteria

  • CKD stage IIIB and IV
  • BMI<35 kg/m2
  • Able to give informed consent

Exclusion Criteria

  • Consuming a diet rich in curcumin or taking curcumin supplements in the past 12 months
  • Life expectancy <1 year
  • Pregnant, breastfeeding, or unwilling to use adequate birth control
  • Uncontrolled hypertension
  • Severe liver disease
  • Severe congestive heart failure
  • Hospitalization within the last 3 months
  • Active infection or antibiotic therapy
  • Immunosuppressive therapy within the last year
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03223883). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search